Bridgewater Associates’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
SBH
RA
Bridgewater Associates's NGVT Position: Q2 2026 in Review
Bridgewater Associates increased its Ingevity (NGVT) stake by 20% in Q2 2026, buying an estimated $247K and bringing the position to 20,799 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #768.
Bridgewater Associates first reported a position in NGVT in Q3 2023 and has held it in 7 quarters since. The position peaked at $5M in Q3 2023. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.
- Bridgewater Associates held 20,799 shares of Ingevity worth $1.55M as of Q2 2026.
- Bridgewater Associates bought 3,433 Ingevity shares in Q2 2026, an estimated $247K.
- Ingevity made up 0.01% of Bridgewater Associates's portfolio in Q2 2026, its #768 holding.
- Bridgewater Associates first reported a position in Ingevity in Q3 2023 and has held it in 7 quarters since.
- Bridgewater Associates's Ingevity position peaked at $5M in Q3 2023.
- 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.
Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.